Call for expressions of interest/nominations for
ISN-ACT Committee Members
The ISN welcomes expressions of interest/nominations for the position of members of the ISN-ACT (Advancing Clinical Trials) Committee. The member positions will start at the World Congress of Nephrology 2024 (WCN’24).
About the ISN-ACT Committee
The aim of the ISN-ACT Committee of the ISN-ACT initiative is to guide facilitation in the increase of international high-quality clinical trials in nephrology, informing the optimal prevention and treatment of kidney disease and its complications for the benefit of patients. The ISN-ACT Committee advances this aim through a series of activities and initiatives.
The Role
Contribute to the delivery of the ISN-ACT Committee objectives, as follows:
- Objective 1: Bring together people involved in clinical trials and related studies in nephrology
- Objective 2: Provide a forum for the discussion of key scientific, operational and analytical issues facing clinical trial researchers in kidney diseases
- Objective 3: Help grow the capacity of the global nephrology community to conduct high quality clinical trials and studies by connecting researchers with different levels of experience, and through specific training and educational initiatives within the ISN framework
- Objective 4: Develop ISN led and/or supported activities that help to improve and standardize high-quality trial conduct in nephrology
- Objective 5: Promote and support the development and execution of clinical trials in a highly ethical framework
- Objective 6: Increase the participation of ISN Regional Boards to consolidate local knowledge
- Objective 7: Oversee the deliverables of ISN-ACT
Selection Criteria
- Demonstrated and strong interest in clinical trials in nephrology, with at least 2 years’ experience in the field
- ISN member in good standing
- Email accessible and able to regularly connect to conference calls
- Thank you for your interest. The application process closed at 5 pm CEST on Friday, 27 October. We encourage you to keep an eye out and apply for available positions at next year’s call for EOIs/nominations round.
Additional information
The position will start at WCN’24 for an initial term of approximately 2-years until WCN’26. The position may be renewed for up to two further terms, to a maximum of approximately 6-years (note: renewal is not automatic and based on group’s needs). Timeline – October: Application period open. November: Positions decided by ISN leadership. December: Applicants notified of outcome.
Learn more about:
- Research at the ISN
- the ISN-ACT (Advancing Clinical Trials)
- the ISN-ACT Committee
- this position or if you have questions by emailing research@theisn.org, cc: mmichael@theisn.org